THYROID CARCINOMA-ASSOCIATED GENETIC MUTATIONS ALSO OCCUR IN THYROID LYMPHOMAS

Molecular testing for mutations activating the mitogen-associated protein kinase signaling pathway is being used to help diagnose thyroid carcinomas. However, the prevalence of these mutations in thyroid lymphomas has not been reported. Therefore, we studied the prevalence of BRAF, NRAS, HRAS, and K...

Descripción completa

Detalles Bibliográficos
Autores principales: Aggarwal, Nidhi, Swerdlow, Steven H., Kelly, Lindsey M., Ogilvie, Jennifer B., Nikiforova, Mariana N., Sathanoori, Malini, Nikiforov, Yuri E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434253/
https://www.ncbi.nlm.nih.gov/pubmed/22575864
http://dx.doi.org/10.1038/modpathol.2012.73

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434253/
https://www.ncbi.nlm.nih.gov/pubmed/22575864
http://dx.doi.org/10.1038/modpathol.2012.73

Ejemplares similares